Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

bacteria exposed to antibiotics in front-loaded staccato bursts, or "pulses," are killed more efficiently and effectively than those under standard treatment regimens. Based on this finding, MiddleBrook has developed a proprietary, once-a-day pulsatile delivery technology called PULSYS(TM). By examining the resistance patterns of bacteria and applying its delivery technologies, MiddleBrook has the potential to redefine infectious disease therapy and significantly improve drug efficacy, shorten length of therapy, and reduce drug resistance versus currently available antibacterial products. For more on MiddleBrook, please visit http://www.middlebrookpharma.com.

About Keflex:

Keflex(R) (cephalexin capsules, USP) is a first-generation cephalosporin antibiotic shown to be active against strains of both gram-positive and gram- negative aerobes in vitro and in clinical infections. Keflex is indicated for treatment of the following infections: respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections. More information on Keflex and prescribing information are available at http://www.middlebrookpharma.com/products_antibiotics/keflex_antibiotics.as px.

This announcement contains historical financial information as of and for three-month and nine-month periods ended September 30, 2007 and September 30, 2006 that is unaudited, and MiddleBrook assumes no obligation to update this information based on new information or future performance except as may be specifically required by applicable law or regulation. The unaudited annual financial information is subject to audit by independent accountants on an annual basis following the close of each calendar year.

This announcement contains forward-looking statements within th
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Monkton, MD (PRWEB) May 04, 2015 ... affecting families for generations. While it can have ... in disabling and catastrophic events. Hereditary Hemorrhagic Telangiectasia ... of blood vessels that lack normal capillary connections between ... nose can cause frequent, severe nosebleeds, but may also ...
(Date:5/4/2015)... York, New York (PRWEB) May 04, 2015 ... much as $2.4 billion to settle thousands of Actos ... 2 diabetes medication increases the risk that a patient ... issued on April 28th, if 95% of those eligible ... will resolve nearly 9,000 bladder cancer cases currently pending ...
(Date:5/4/2015)... “ LiveSchool ” was featured on NewsWatch ... look at the latest and coolest applications on the ... host of AppWatch and technology expert, conducted the app ... teachers to reward students with good behavior. , Positive ... the classroom. And the good people at LiveSchool ...
(Date:5/4/2015)... May 04, 2015 Baptist Medical ... Stroke Association’s Get With The Guidelines®-Stroke Gold Plus ... Honor Roll. The award recognizes the hospital’s commitment ... the most appropriate treatment according to nationally recognized, ... , To receive the Gold Plus Quality Achievement ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Ticket Down is ... International Champions Cup (ICC) . While the World Cup ... is held every four years, the International Champions Cup is ... tournament saw the all-time attendance record for soccer in the ... the Big House at the University of Michigan. This year, ...
Breaking Medicine News(10 mins):Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4
... Anorexia Nervosa is a condition that usually affects young women ... it is due to overactive dopamine receptors in the basal ... nervosa are driven to be excessively thin and are unaware ... Nervosa, many will remember the death of the famous talented ...
... A new study by the researchers of University of British ... but a help to our concentration and efficiency, more so ... maintain their balance. ,Noise is often thought as the ... subjects we want to concentrate upon. Noise is often related ...
... In a major breakthrough in the advancement of ... scan rare genetic mutation at a fraction of ... array diagonal gel electrophoresis. ,The technology devised ... in collaboration with Bristol, University college London, British ...
... circumcision is likely to reduce the risk of contacting HIV ... recent study involved 3,000 HIV negative men in Africa between ... were not circumcised. They were followed up for ... uncircumcised men who became infected with HIV, only an estimated ...
... early health check up programs and attend// kindergarten at ... than those who do not. ,A research study ... had participated early in these health and educational programs ... Boston and Boston College had conducted the Brookline Early ...
... judgment passed by the ‘Delhi High Court’ on Tuesday Justice Vikramjit ... Manju a 12 year old for the wrong treatment administered by ... informed in the next few days how much compensation was the ... enquiry had indicated that the operation for total hip replacement and ...
Cached Medicine News:Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 3
(Date:5/4/2015)... 2015 DePuy Synthes CMF* today announced the ... commercially available biosynthesized dural replacement derived from cellulose for ... of the DePuy Synthes Companies of Johnson & Johnson. ... covers and protects the brain and spinal cord. During ... to access the brain. A dural graft, which is ...
(Date:5/4/2015)... board of directors of Eli Lilly and Company (NYSE: ... of 2015 of $0.50 per share on outstanding common stock. ... to shareholders of record at the close of business on ... is a global healthcare leader that unites caring with discovery ... were founded more than a century ago by a man ...
(Date:5/4/2015)... SOMERSET, N.J. , May 4, 2015 ... 20 percent seek help. During May – National Hearing ... hearing loss could be missing out on the sounds ... through the trees. To ensure that you ... sounds that color our world, Oticon, Inc. offers practical ...
Breaking Medicine Technology:DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 3It's Better Hearing Month 2
Inquire...
... • V-shaped bottom allows easy ... or 5 per bag ,• Corner ... Pipettor Solution Basin designed for 4, 8, ... V-shaped bottom permits withdrawal of practically all ...
... Calibration Software monitors and documents the accuracy ... entire operating life. This new program was ... from gravimetric or photometric pipette tests. It ... types from various manufacturers and other liquid ...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile...
Medicine Products: